FLT3 N676K
|
AML
|
FLT3 N676K
|
AML
|
midostaurin Resistant: C4 – Case Studies
|
midostaurin Resistant: C4 – Case Studies
|
FLT3 N676K
|
AML
|
FLT3 N676K
|
AML
|
LY2801653 Sensitive: C4 – Case Studies
|
LY2801653 Sensitive: C4 – Case Studies
|
FLT3 N676K
|
AML
|
FLT3 N676K
|
AML
|
gilteritinib Sensitive: C4 – Case Studies
|
gilteritinib Sensitive: C4 – Case Studies
|
FLT3 N676K
|
AML
|
FLT3 N676K
|
AML
|
quizartinib Resistant: D – Preclinical
|
quizartinib Resistant: D – Preclinical
|